IN8bio (INAB) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free INAB Stock Alerts $1.13 +0.09 (+8.65%) (As of 03:59 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media IN8bio Short Interest DataCurrent Short Volume179,900 sharesPrevious Short Volume512,000 sharesChange Vs. Previous Month-64.86%Dollar Volume Sold Short$183,498.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares44,120,000 sharesFloat Size29,770,000 sharesShort Percent of Float0.60%Today's Trading Volume793,988 sharesAverage Trading Volume285,135 sharesToday's Volume Vs. Average278% Short Selling IN8bio ? Sign up to receive the latest short interest report for IN8bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINAB Short Interest Over TimeINAB Days to Cover Over TimeINAB Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. IN8bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024179,900 shares $183,498.00 -64.9%0.6%0.5 $1.02 4/15/2024512,000 shares $522,240.00 +892.3%1.8%1.5 $1.02 3/31/202451,600 shares $60,888.00 -39.2%0.2%0.3 $1.18 3/15/202484,800 shares $96,672.00 +296.3%0.3%0.5 $1.14 2/29/202421,400 shares $23,754.00 -47.9%0.1%0 $1.11 2/15/202441,100 shares $45,210.00 -68.1%0.1%0.1 $1.10 Get the Latest News and Ratings for INAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IN8bio and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024129,000 shares $167,700.00 +49.1%0.5%0.2 $1.30 1/15/202486,500 shares $131,480.00 -25.5%0.4%0.1 $1.52 12/31/2023116,100 shares $160,218.00 -77.9%0.7%0.2 $1.38 12/15/2023525,200 shares $1.00 million +490.1%2.9%0.9 $1.91 11/30/202389,000 shares $73,870.00 +222.5%0.4%0.6 $0.83 11/15/202327,600 shares $25,930.20 -51.0%0.1%0.3 $0.94 10/31/202356,300 shares $55,168.37 -0.2%0.3%0.7 $0.98 10/15/202356,400 shares $52,722.72 -43.1%0.3%0.5 $0.93 9/30/202399,100 shares $103,064.00 +166.4%0.5%0.8 $1.04 9/15/202337,200 shares $34,224.00 -57.4%0.2%0.3 $0.92 8/31/202387,300 shares $91,665.00 +90.2%0.4%0.5 $1.05 8/15/202345,900 shares $54,621.00 +81.4%0.2%0.2 $1.19 7/31/202325,300 shares $29,854.00 -70.1%0.1%0.1 $1.18 7/15/202384,700 shares $137,214.00 +22.2%0.6%0 $1.62 6/30/202369,300 shares $106,722.00 -21.9%0.5%0 $1.54 6/15/202388,700 shares $188,044.00 +14.8%0.6%0 $2.12 5/31/202377,300 shares $234,992.00 -43.8%0.6%0 $3.04 5/15/2023137,500 shares $338,250.00 -88.5%1.1%0 $2.46 4/30/20231,190,000 shares $1.74 million +720.7%13.5%0.3 $1.46 4/15/2023145,000 shares $175,450.00 -3.0%1.7%0.1 $1.21 3/31/2023149,500 shares $194,350.00 -9.4%1.7%1.9 $1.30 3/15/2023165,000 shares $219,450.00 -20.6%1.9%1.8 $1.33 2/28/2023207,800 shares $317,934.00 +127.4%2.4%2.2 $1.53 2/15/202391,400 shares $182,800.00 -13.7%1.1%1 $2.00 1/31/2023105,900 shares $243,146.40 -10.3%1.2%1.7 $2.30 1/15/2023118,000 shares $272,580.00 -10.4%1.4%1.9 $2.31 12/30/2022131,700 shares $304,227.00 +28.5%1.5%2 $2.31 12/15/2022102,500 shares $187,575.00 +45.8%1.2%1.7 $1.83 11/30/202270,300 shares $122,322.00 +42.9%0.8%1.1 $1.74 11/15/202249,200 shares $77,736.00 +21.8%0.6%0 $1.58 10/31/202240,400 shares $78,780.00 -9.0%0.5%0 $1.95 10/15/202244,400 shares $89,244.00 -13.3%0.5%0 $2.01 9/30/202251,200 shares $103,424.00 -40.5%0.6%0 $2.02 9/15/202286,100 shares $237,636.00 +154.7%1.0%0.1 $2.76Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. INAB Short Interest - Frequently Asked Questions What is IN8bio's current short interest? Short interest is the volume of IN8bio shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 179,900 shares of INAB short. 0.60% of IN8bio's shares are currently sold short. Learn More on IN8bio's current short interest. What is a good short interest percentage for IN8bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.60% of IN8bio's floating shares are currently sold short. Is IN8bio's short interest increasing or decreasing? IN8bio saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 179,900 shares, a drop of 64.9% from the previous total of 512,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is IN8bio's float size? IN8bio currently has issued a total of 44,120,000 shares. Some of IN8bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IN8bio currently has a public float of 29,770,000 shares. How does IN8bio's short interest compare to its competitors? 0.60% of IN8bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to IN8bio: Dyadic International, Inc. (0.96%), HCW Biologics Inc. (0.05%), OKYO Pharma Limited (0.43%), Cyclo Therapeutics, Inc. (0.35%), Aligos Therapeutics, Inc. (1.11%), Quince Therapeutics, Inc. (6.58%), MiNK Therapeutics, Inc. (0.88%), Estrella Immunopharma, Inc. (0.12%), SAB Biotherapeutics, Inc. (0.30%), Achilles Therapeutics plc (0.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short IN8bio stock? Short selling INAB is an investing strategy that aims to generate trading profit from IN8bio as its price is falling. INAB shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IN8bio? A short squeeze for IN8bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INAB, which in turn drives the price of the stock up even further. How often is IN8bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INAB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: DYAI Short Interest HCWB Short Interest OKYO Short Interest CYTH Short Interest ALGS Short Interest QNCX Short Interest INKT Short Interest ESLA Short Interest SABS Short Interest ACHL Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INAB) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersDoes this make you sick?Allegiance GoldThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News